Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy

BACKGROUND: Chemotherapy with docetaxel (Doc) remains the standard treatment for metastatic and castration-resistance prostate cancer (CRPC). However, the clinical success of Doc is limited by its chemoresistance and side effects. This study investigated whether natural products green tea (GT) and q...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Piwen, Henning, Susanne M., Magyar, Clara E., Elshimali, Yahya, Heber, David, Vadgama, Jaydutt V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858851/
https://www.ncbi.nlm.nih.gov/pubmed/27151407
http://dx.doi.org/10.1186/s13046-016-0351-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858851/
https://www.ncbi.nlm.nih.gov/pubmed/27151407
http://dx.doi.org/10.1186/s13046-016-0351-x

Ejemplares similares